All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ1683 | Anti-ORC6 (C6.5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C6.5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1684 | Anti-ORC6 (2679C2b) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2679C2b | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1685 | Anti-ORC6 (CBXO-0285) h(41BB-CD3ζ) CAR, pCDCAR1 | Hamster, Human, Monkey, Mouse, Rat | CBXO-0285 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1686 | Anti-ORC6 (3A4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3A4 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1687 | Anti-ORC6 (CBXO-0286) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0286 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5107 | Anti-ORC6 (C6.5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | C6.5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5108 | Anti-ORC6 (2679C2b) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2679C2b | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5109 | Anti-ORC6 (CBXO-0285) h(CD28-CD3ζ) CAR, pCDCAR1 | Hamster, Human, Monkey, Mouse, Rat | CBXO-0285 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5110 | Anti-ORC6 (3A4) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3A4 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5111 | Anti-ORC6 (CBXO-0286) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXO-0286 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION